INO · Transaction Sep 8, 2020 · Filed Nov 6, 2020 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · INO
-1.66% · -$0.0201 · Vol 5.0M
Market closed · last close 4:00 PM ET · price as of 19:59:02 ET
Inovio Pharmaceuticals Inc
Biotechnology
$1.19
Veridion Score
BETALOW CONF · 6/6 factorsFri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET · INO
MethodologyINO
Inovio Pharmaceuticals Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
52/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is INO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Inovio Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONSListed since
1998
Employees
112
Country
US
Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$1.23
Day high
$1.24
Day low
$1.15
Previous close
$1.21
52W high
$2.87
-58.54% from high
52W low
$0.6560
24% of range
Market cap
$122M
EPS
$-1.8300
Beta
-0.39
Shares out
103.4M
Volume
5M
1.02× rel vol
Avg volume
4.9M
VWAP
$1.19
Price history computed in-house
1W
+3.47%
1M
+22.66%
3M
-5.56%
1Y
-39.29%
YTD
-31.61%
SMA 50 $1.04 · above
SMA 200 $1.47 · below
52W position 24%
INO overview
Related filings and maps
Public disclosures
Congress activity in INO
Official filing ↗
Federal contracts
INO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INO in this window.
Lobbying spend
INO lobbying filings, year to date.
Registered lobbying filings matched to Inovio Pharmaceuticals Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INO in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for INO.
Options
Sovereign unlock shows live options positioning for INO.